InflaRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.

About IFRX

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. 

CEO
Niels Christoph Riedemann
CEONiels Christoph Riedemann
Employees
74
Employees74
Headquarters
Jena, Thueringen
HeadquartersJena, Thueringen
Founded
2007
Founded2007
Employees
74
Employees74

IFRX Key Statistics

Market cap
61.42M
Market cap61.42M
Price-Earnings ratio
-0.87
Price-Earnings ratio-0.87
Dividend yield
Dividend yield
Average volume
206.05K
Average volume206.05K
High today
$1.08
High today$1.08
Low today
$0.9066
Low today$0.9066
Open price
$0.9911
Open price$0.9911
Volume
859.11K
Volume859.11K
52 Week high
$1.94
52 Week high$1.94
52 Week low
$0.7113
52 Week low$0.7113

Stock Snapshot

InflaRx(IFRX) stock is priced at $0.91, giving the company a market capitalization of 61.42M. It carries a P/E multiple of -0.87.

As of 2026-03-18, InflaRx(IFRX) stock has fluctuated between $0.91 and $1.08. The current price stands at $0.91, placing the stock +0.6% above today's low and -15.6% off the high.

InflaRx(IFRX) shares are trading with a volume of 859.11K, against a daily average of 206.05K.

During the past year, InflaRx(IFRX) stock moved between $0.71 at its lowest and $1.94 at its peak.

During the past year, InflaRx(IFRX) stock moved between $0.71 at its lowest and $1.94 at its peak.

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own IFRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.